Hirtle Callaghan & Co’s Monsanto Co MON Stock Holding History

Hirtle Callaghan & Co’s Portfolio MON Stock Details MON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-184	Closed	-$22K	–	222
2017 Q3	$22K	Hold	184	–	–	﹤0.01%	149
2017 Q2	$22K	Sell	184 -46	-20%	-$5.37K	﹤0.01%	133
2017 Q1	$26K	Hold	230	–	–	﹤0.01%	134
2016 Q4	$24K	Sell	230 -128	-36%	-$13.1K	﹤0.01%	108
2016 Q3	$37K	Hold	358	–	–	0.01%	151
2016 Q2	$37K	Sell	358 -75	-17%	-$7.43K	0.01%	132
2016 Q1	$39K	Sell	433 -126	-23%	-$11.4K	0.01%	143
2015 Q4	$53K	Sell	559 -1,200	-68%	-$113K	0.01%	125
2015 Q3	$149K	Hold	1,759	–	–	0.03%	99
2015 Q2	$187K	Buy	+1,759	New	+$204K	0.06%	88
2015 Q1	–	Sell	-2,167	Closed	-$259K	–	438
2014 Q4	$259K	Hold	2,167	–	–	0.06%	173
2014 Q3	$244K	Hold	2,167	–	–	0.04%	172
2014 Q2	$270K	Sell	2,167 -2	-0.1%	-$234	0.04%	209
2014 Q1	$247K	Hold	2,169	–	–	0.04%	214
2013 Q4	$253K	Hold	2,169	–	–	0.03%	204
2013 Q3	$226K	Buy	+2,169	New	+$218K	0.04%	212

Other funds holding MON

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Hirtle Callaghan & Co's MON Position: Q4 2017 in Review

Hirtle Callaghan & Co sold out of Monsanto Co (MON) in Q4 2017, closing a stake of 184 shares — an estimated $22K sold.

Hirtle Callaghan & Co first reported a position in MON in Q3 2013 and held it in 16 quarters. The position peaked at $270K in Q2 2014. 1,061 funds tracked by Wall St. Rank hold MON as of Q4 2017.

Hirtle Callaghan & Co reported no remaining Monsanto Co position as of Q4 2017 after selling out during the quarter.
Hirtle Callaghan & Co sold 184 Monsanto Co shares in Q4 2017, an estimated $22K.
Hirtle Callaghan & Co first reported a position in Monsanto Co in Q3 2013 and held it in 16 quarters.
Hirtle Callaghan & Co's Monsanto Co position peaked at $270K in Q2 2014.
1,061 funds tracked by Wall St. Rank held Monsanto Co as of Q4 2017.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2017, filed 17 Jan 2018.